Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses.
about
G-protein-coupled receptor 81 promotes a malignant phenotype in breast cancer through angiogenic factor secretion.Screening of the prognostic targets for breast cancer based co-expression modules analysis.Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis.A Multicenter Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel and Gemcitabine in Locally Advanced Breast Cancer.
P2860
Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prognostic impact of AJCC resp ...... reast cancer subtype analyses.
@en
Prognostic impact of AJCC resp ...... reast cancer subtype analyses.
@nl
type
label
Prognostic impact of AJCC resp ...... reast cancer subtype analyses.
@en
Prognostic impact of AJCC resp ...... reast cancer subtype analyses.
@nl
prefLabel
Prognostic impact of AJCC resp ...... reast cancer subtype analyses.
@en
Prognostic impact of AJCC resp ...... reast cancer subtype analyses.
@nl
P2093
P2860
P1433
P1476
Prognostic impact of AJCC resp ...... reast cancer subtype analyses.
@en
P2093
Bhumsuk Keam
Do-Youn Oh
Dong-Young Noh
Han Suk Ryu
In Ae Park
Kyung-Hun Lee
Sae-Won Han
Seock-Ah Im
Tae-Yong Kim
Tae-You Kim
P2860
P2888
P356
10.1186/S12885-016-2500-1
P407
P577
2016-07-21T00:00:00Z
P6179
1031331858